Navigation Links
Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016
Date:2/9/2010

arketed Products in the Atrial Fibrillation Market 12

3.3.1 Multaq 12

3.3.2 Tikosyn 13

3.3.3 Tambocor 14

3.3.4 Coumadin (Warfarin- Anticoagulants) 15

3.3.5 Betapace AF 16

3.4 Key Takeaway 17

4 Atrial Fibrillation: Pipeline Assessment 18

4.1 Overview 18

4.2 Strategic Pipeline Assessment 18

4.2.1 Technology Trends Analytic Framework 18

4.3 Atrial Fibrillation Therapeutics – Promising Drugs under Clinical Development 20

4.4 Drugs under Clinical Development 20

4.4.1 Xarelto 20

4.4.2 Pradaxa 21

4.4.3 Stedicor 22

4.4.4 Kynapid 23

4.4.5 Edoxaban 24

4.5 Atrial Fibrillation Therapeutics Market – Clinical Pipeline by Mechanism of Action 24

4.6 Atrial Fibrillation Pipeline – Pipeline by Clinical Phases of Development 25

4.6.1 Atrial Fibrillation Therapeutics – Phase III Clinical Pipeline 26

4.6.2 Atrial Fibrillation Therapeutics – Phase II Clinical Pipeline 27

4.6.3 Atrial Fibrillation Therapeutics – Phase I Clinical Pipeline 27

4.6.4 Atrial Fibrillation Therapeutics – Preclinical Pipeline 27

4.7 Discontinued / Suspended Drugs for Atrial Fibrillation 28

4.8 Key Takeaway 28

5 Atrial Fibrillation Market: Implications for Future Market Competition 29

6 Atrial Fibrillation Market: Future Players in the Atrial Fibrillation Market 30

6.1 Introduction 30

6.2 Cardiome Pharma Corp and Astellas Pharma US, Inc 30

6.2.1 Overview 30

6.2.2 Business Description 31

6.2.3 CV Portfolio 31

6.2.4 Atrial Fibrillation Product Portfolio 31

6.3 Sanofi Aventis 33

6.3.1 Overview 33

6.3.2 Business Descr
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Reportlinker Adds World Wound Management Products
2. Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
3. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
4. Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
5. Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. Reportlinker Adds Top Ten Worlds Leading Orthopedics Companies
8. Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
9. Reportlinker Adds Medical Fiber Optics - A World Market Analysis
10. Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities
11. Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- A decade-long JDRF-funded study led by the Institute ... Germany , is providing a deeper understanding of ... type 1 diabetes (T1D), highlighting the importance of pre-diabetes ... "Seroconversion to Multiple Islet Autoantibodies and Risk of Progression ... The Journal of the American Medical Association . ...
(Date:6/19/2013)... 19, 2013  Finesse Solutions, Inc, a manufacturer ... process applications, announced the launch of its new ... culture and fermentation.  The 3L glass vessels are ... Finesse bioreactors and are designed to optimize yield ... fully compatible with all Finesse G3Lab controllers, and ...
(Date:6/19/2013)... 19, 2013  Decision Resources, one of the ... and healthcare issues, finds that, for the treatment ... and European rheumatologists cite a therapy,s induction of ... influences their prescribing decisions. Over 60 percent and ... rank the percentage of patients achieving remission at ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2
... 2011 Cell Therapeutics, Inc. ("CTI" or the "Company") ... results for the first quarter ended March 31, 2011. ... million through two financings, advanced pixantrone into a confirmatory ... Therapeutics Ltd. ("Chroma") to co-develop and market Chroma,s drug ...
... April 26, 2011 BD (Becton, Dickinson and Company) ... technology company, today reported quarterly revenues of $1.922 billion ... representing an increase of 6.8 percent from the prior-year ... percent, despite an unfavorable comparison to the prior year ...
Cached Medicine Technology:Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 2Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 3Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 4Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 5Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 6BD Announces Results for 2011 Second Fiscal Quarter 2BD Announces Results for 2011 Second Fiscal Quarter 3BD Announces Results for 2011 Second Fiscal Quarter 4BD Announces Results for 2011 Second Fiscal Quarter 5BD Announces Results for 2011 Second Fiscal Quarter 6BD Announces Results for 2011 Second Fiscal Quarter 7BD Announces Results for 2011 Second Fiscal Quarter 8BD Announces Results for 2011 Second Fiscal Quarter 9BD Announces Results for 2011 Second Fiscal Quarter 10BD Announces Results for 2011 Second Fiscal Quarter 11BD Announces Results for 2011 Second Fiscal Quarter 12BD Announces Results for 2011 Second Fiscal Quarter 13BD Announces Results for 2011 Second Fiscal Quarter 14
(Date:6/19/2013)... FL (PRWEB) June 19, 2013 At a ... the positive changes and growth that has occurred over the ... travel club. , Shuman said, "Travel Services has added vendors, ... heights beyond belief. Membership is up, even in the ... meet the demands of members." , Having been in the ...
(Date:6/19/2013)... In 2011, the value of the Serbian ... drugs form the largest sector, accounting for nearly one ... is a significant contributor to the local economy; it ... 50% of the total domestic chemical industry output fall ... and Zdravlje Actavis are key participants in the Serbian ...
(Date:6/19/2013)... the brink of extinction but can we finish the ... a Bristol academic addresses in his new book, published next ... University of Bristol, has produced the first comprehensive history of ... of polio explores the experiences of victims alongside the medical ... , According to a review by The Lancet ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Ultimate Medical ... Telethon, an 11.5-hour broadcast on WFLA News Channel 8. ... collected more than $84 million for All Children's Hospital ... event, themed "30 Years of Miracles," marked the second ... 18 UMA employees worked the phones during the Telethon, ...
(Date:6/19/2013)... Lexington, Mass. (PRWEB) June 19, 2013 ... IT security solutions, today announced that Imprivata OneSign ... KLAS® 2013 Mid-Term Performance Review: Software & Services ... by KLAS laud Imprivata on the superior performance of ... and support, and they indicate that Imprivata is integral ...
Breaking Medicine News(10 mins):Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2Health News:Paralysed with fear: The story of polio 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3
... , ALLEGAN, Mich., Nov. 9 Perrigo Company (Nasdaq: ... C. Papa will present at the Credit Suisse 18th ... 11:00 p.m. (MT) at the Arizona Biltmore Hotel in ... global healthcare supplier that develops, manufactures and distributes OTC ...
... Simple computerized alerts can help curb the impulse ... study in the August issue of Journal ... clinicians received computerized alerts, which compared medication brands, ... heavily marketed sleep medications to comparable generic equivalents. ...
... Research carried out among thousands of people has shown ... mass, leading to osteoporosis and fractures. This was ... head of the Brain and Behavior Laboratory, and Prof. Itai ... the relationship between depression and bone loss is particularly strong ...
... the clock 8 years, research shows , MONDAY, Nov. 9 ... improves so much that most feel eight years younger, a new ... everyone except a small minority -- only 2 percent -- who ... "The results really say three things: That work puts an extra ...
... announced today the acquisition of App Tech Global, Inc., which ... Natural Nutrition,s name will be changed to App Tech, Corp. ... of App Tech Global, Inc. , App Tech is developing ... App Tech is focused on multi platform apps designed ...
... China, Nov. 9 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... leading pharmaceutical company,specializing in the development, manufacturing, and ... today announced an agreement,to acquire the manufacturing license ... Ltd. ("Tianda"). The acquisition of the,manufacturing license will ...
Cached Medicine News:Health News:Computerized support keeps prominence of name brand drugs at bay 2Health News:Connection between depression and osteoporosis detailed by Hebrew University researchers 2Health News:Retirement Brings Most a Big Health Boost 2Health News:Retirement Brings Most a Big Health Boost 3Health News:Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
10 L, Bulk Recommended for 5 and 10 L pipettes. Ideal for pipetting into long, narrow tubes or deep well plates....
This extended 10 L tip additionally combats contamination by keeping your pipettor out of 1.5 L and 2.0 L tubes....
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
Medicine Products: